期刊文献+

长沙地区人群骨密度检测及骨质疏松症分析 被引量:8

Analysis of people's BMD and osteoporosis in Changsha area
下载PDF
导出
摘要 目的通过872例长沙地区健康人群骨密度测定,为了解和研究长沙地区人群的骨密度(BMD)变化规律及骨质疏松症(Osteoporosis,OP)的发病状况,建立长沙地区骨密度正常参考值提供依据。方法用双能X线骨密度测量分析仪(DEXA)对长沙地区20-85岁的健康人群1331人BMD检测。男性624人,女性707人,按10岁一个年龄组进行统计分析。结果男性骨密度峰值在20-29岁,而女性骨密度峰值出现在30-39年龄段,然后随着年龄段的增高BMD逐渐下降,50岁以上女性和60岁以上男性的骨量呈迅速下降趋势(P<0.01);且骨质疏松发生率则女性显著高于男性(P<0.01)。结论骨质疏松发病率与年龄和性别具有一定的相关性。骨密度随年龄增长而下降,骨质疏松发病率随之增加,女性骨质疏松患病率高于男性。故女性骨质疏松的预防治疗应及早入手。 【Objective】To determine bone mineral density(BMD) of normal people in Changsha area and further to investigate the bone mineral density(BMD) changes and osteoporosis(Osteoporosis,OP) of the disease status.To establish of normal reference values and provide the basis for bone mineral density in Changsha area.【Methods】 BMD of lumber spine and proximal femur in 1 331(624 men,707 women) healthy people were determined by duel energy X-ray BMD detector(DEXA) in Changsha residents aged from 20 to 85 years old.All subjects were divided into different groups by 10 years for statistical analysis.【Results】The man peak bone mass was found between 20~ 29 years of age.But the female peak bone mass was found between 30 ~39 years of age.Female's bone mass decreased quickly after the age of 50.Man's bone mass decreased quickly after the age of 60(P〈0.01).The incidence of osteoporosis in women was significantly higher than men(P〈0.01).【Conclusions】The incidence of osteoporosis has some relevance with age and gender.BMD decreased with age,increased incidence of osteoporosis and female prevalence of osteoporosis in men.Therefore,prevention and treatment of osteoporosis in women should start as soon as possible.
作者 唐韬 韩辉武
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2013年第19期61-63,共3页 China Journal of Modern Medicine
关键词 骨密度 骨质疏松症 峰值 bone mineral density osteoporosis peak bone mass
  • 相关文献

参考文献3

二级参考文献6

共引文献139

同被引文献65

  • 1沈夏英,沈序英,邝海东,刘仲华.社区骨质疏松防治健康教育模式探讨[J].当代医学,2008,14(14):13-16. 被引量:9
  • 2刘学军.骨质疏松症[J].中国矫形外科杂志,2006,14(21):1668-1670. 被引量:26
  • 3彭涛,许衍挺,包华东,刘晓明.综合干预措施对社区老年人骨质疏松症的效果评估[J].广东医学,2007,28(4):612-614. 被引量:14
  • 4GARNERO P, SORNAY-RENDU E, MUNOZ F, et al. Associa- tion of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in post- menopausal women: the OFELY study[J]. Osteoporosis Interna- tional, 2013, 24(2): 489-494.
  • 5TUZUN S, ESKIYURT N, AKARIRMAK U, et al. Incidence ofhip fracture and prevalence of osteoporosis in Turkey: the FRACTURK study [J]. Osteoporosis International, 2012, 23 (3): 949-955.
  • 6POLYZOS SA, ANASTASILAKIS AD, BRATENGEIER C, et al. Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women-the six-month effect of risedronate and teriparatide[J]. Osteoporosis International, 2012, 23(3): 1171-1176.
  • 7MOUSTAFA A, SUGIYAMA T, PRASAD J, et al. Mechanical loading-related changes in osteocyte sclerostin expression in mice are more closely associated with the subsequent osteogenic re- sponse than the peak strains engendered[J]. Osteoporosis Interna- tional, 2012, 23(4): 1225-1234.
  • 8ARASU A, CAWTHON PM, LUI LY, et al. Serum sclerostin and risk of hip fracture in older Caucasian women[J]. Journal of Clin- ical Endocrinology & Metabolism, 2012, 97(6): 2027-2032.
  • 9VAN LIEROP AH, HAMDY NAT, VAN BEZOOIJEN RL, et al. The role of sclerostin in the pathophysiology of sclerosing bone dysplasias [J]. Clinical Reviews in Bone and Mineral Metabolism, 2012, 10(2): 108-116.
  • 10GRETHEN E, HILL KM, JONES RM, et al. Serum leptin, parathyroid hormone, 1, 25-dihydroxyvitamin D, fibroblast growth factor 23, bone alkaline phosphatase, and sclerostin re- lationships in obesity[J]. Journal of Clinical Endocrinology & Metabolism, 2012, 97(5): 1655-1662.

引证文献8

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部